Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung, James A. Wells
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis Group 2021-01-01
Serija:mAbs
Teme:
Bispecific
neutralizing antibody
knob-in-hole
COVID-19
SARS-CoV-2
Online pristup:https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items